Tujeo SoloStar na Lantus bụ ọgwụ hypoglycemic. Na isi ya, ndị a bụ ọgwụ analogues na-arụ ọrụ ogologo oge. A na-eji ha maka ụdị ọrịa shuga mellitus 1 na nke 2, mgbe ọkwa glucose adaghị na ọkwa nkịtị na-ejighị ọgwụ insulin. N'ihi ọgwụ ndị a, ego shuga dị n'ọbara nọ n'ọkwa kwesịrị ekwesị.
Ihe njiri mara ọgwụ Tujo SoloStar
Nke a bụ ọgwụ hypoglycemic nke ịgbatị ihe, ihe bụ isi bụ nke insulin glargine. Ọ gụnyere ihe ndị ọzọ dị ka zinc chloride, metacresol, hydrochloric acid, sodium hydroxide, glycerol, mmiri maka ntụtụ. Ogwu ahu di n’udi iji dozie ya. 1 ml nke ọgwụ nwere 10.91 mg nke insulin glargine. A na-emepụta ọgwụ a na katridges ya na mkpịsị pirinji pụrụ iche, nke enyere aka na tebụl ọgwụ.
Tujeo SoloStar na Lantus bụ ọgwụ hypoglycemic.
Ọgwụ nwere mmetụta glycemic, ya bụ, nwayọ ma ogologo oge na-ebelata ọkwa shuga dị n’ọbara. Oge ọrụ ahụ dị awa 24-34. Ọgwụ na-enyere aka ịbawanye njikọ protein na-egbochi ịmepụta shuga na imeju. N'okpuru omume ya, glucose na-abanyekwu arụ ọrụ nke anụ ahụ.
Ihe ngosi maka iji - ụdị 1 na ụdị ọrịa shuga mellitus 2, nke a chọrọ insulin. A na-eji ọgwụ ahụ eme ihe naanị. Ọ bụrụ na emee nke a site na intraven, ọ nwere ike ibute nnukwu hypoglycemia.
Ejila ogwu na oyi. A na-anakọta ọgwụ dị mkpa na pen sirinji, na-achịkwa ndị gosipụtara na windo ngosipụta pụrụ iche. Ikwesiri itinye insulin banye na abụba dị n'okpuru nke ubu, apata ụkwụ ma ọ bụ afọ, na-enweghị ibitụ bọtịnụ dosing aka. Mgbe nke ahụ gasị, tinye mkpịsị aka ukwu na bọtịnụ ahụ, pịa ya ụzọ ma jide ya ruo mgbe nọmba 0 pụtara na windo .. Jiri nwayọ wepu ya ma wepụ agịga ahụ n'akpụkpọ ahụ. A ga-enyerịrị ntụtụ ọ bụla ịgbanye ebe dị iche iche na ahụ.
Ihe mgbochi:
- afọ ruo afọ 18;
- hypersensitivity na ọgwụ nke ọgwụ.
N'iji nlezianya na -eme ọgwụ ahụ maka ndị ọrịa agadi, ndị mmadụ nwere ọrịa akụrụ na ọrịa imeju, ọrịa endocrine.
Iji ọgwụ nwere ike ibute nsonaazụ ndị ọzọ. Ọtụtụ mgbe, hypoglycemia na-apụta. Ọzọkwa a hụrụ:
- mmeghachi omume nfụkasị ahụ;
- enweghi ike ịhụ anya;
- mmeghachi omume mpaghara na mpaghara nchịkwa ọgwụ - ịcha ọbara ọbara, ọzịza, itching;
- lipoatrophy na lipohypertrophy.
Kedu ka Lantus si arụ ọrụ?
Lantus bụ ọgwụ hypoglycemic dị ogologo oge. Akụkụ bụ isi ya bụ glargine insulin, nke bụ analog zuru oke nke insulin mmadụ. Ọ dị n'ụdị edozi anya maka nchịkwa subcutaneous na iko ma ọ bụ katrized.
Ọgwụ a webatara na abụba dị n'okpuru nwere mmetụta ndị a:
- na - eduga n'ịkpụpụta microprecipitate, n'ihi nke a na - ahapụ obere insulin n'oge niile, nke na - enyere aka ịbelata shuga dị mma;
- na-achịkwa metabolism nke plasma glucose, na -ebelata ego ya n'ihi ịba ụba nke anụ ahụ na-emetụta oke;
- na - eduga n'ịba ụba protein, ebe lipolysis na proteolysis na adipocytes na - agbagide n'otu oge.
Ọ nwere mmetụta na-adịte aka n'ihi mbelata nke mmịpụta, nke na-enye ohere ịnye ọgwụ ahụ otu ugboro n'ụbọchị. Ọgwụ na-amalite ime otu awa mgbe nchịkwa gasịrị.
E gosipụtara Lantus maka ụdị insulin na-akpata insulin mellitus na ụdị ọrịa shuga na-abụghị insulin na-adabere.
Contraindications:
- ọgwụ mgbochi na akụkụ nke ọgwụ ahụ;
- ụmụaka na-erubeghị afọ isii.
N'iji nlezianya, edere ya n’oge ime. A na-etinye ọgwụ ahụ n'ime anụ ahụ dị n'okpuru ala nke ihe mgbochi ahụ, mgbidi afọ, akụkụ, na apata ụkwụ n'otu oge, kwa ụbọchị na-agba ọgwụ na ebe ọzọ.
Ọ bụrụ na akwadoghị ọgwụ na-ezighi ezi, mmetụta ọjọọ nwere ike ịmalite. Ihe kachasị ewu ewu gụnyere hypoglycemia, ụdị siri ike nke nwere ike ịkpasu mmebi nke sistemụ akwara. Ihe nrịba ama ya bu tachycardia, mmiri nke oke ọsụsọ na-egbu, oke iwe, agụụ oge niile. N'ọdịnihu, nsogbu ọria akwara ga-ebilite, ya na mmụọ nzuzu, ọrịa nkwarụ, na ịda mba.
Nsonaazụ gụnyere nsụchi anya. Nnukwu shuga dị n'ọbara na-eduga n'inwe mmepe nke ọrịa mamịrị retinopathy. Mmeghachi omume Allergic anaghị adịkarị n'ụdị edema, mbufụt, urticaria, itching, na redness.
Ntụnyere Ọgwụ
Tujeo SoloStar na Lantus nwere ngwongwo yiri ya na ụfọdụ iche.
Mmekorita
Abụọ ọgwụ bụ ọgwụ nwere insulin nke dị ka ntụtụ ya n'ime oghere sirinji dị adaba. Ala nke ọ bụla nwere otu mkpụrụ ọgwụ. Iji mee ọgwụ, a ga-emeghe sirinji, wepu okpu ahụ ma dobe ihe dị n'ime ya na agịga ejiri.
Ọgwụ ndị a nwere otu ihe arụ ọrụ - insulin glargine, nke bụ analog nke insulin na-emepụta n'ime ahụ mmadụ. A na-ewebata ọgwụ n’ahụ n’ahụ.
Edere ọgwụ maka ọrịa shuga. Ha enweghi ọgwụ mgbochi na mmetụta ọ bụla.
Edere ọgwụ maka ọrịa shuga.
Kedu ihe dị iche?
Ogwu nwere ndi iche:
- ihe na-arụ ọrụ n'ime 1 ml nwere ọtụtụ ọnụọgụ;
- Ahapụrụ Lantus site na afọ 6, Tugeo Solostar - site na afọ 18;
- A na-emepụta Lantus n'ime karama na katriji, Tujeo - bụ naanị na katriji.
Na mgbakwunye, iwere Tujeo adịkarịghị eduga n'ọrịa hypoglycemia. Ọgwụ na-egosi mmetụta ka gbatịkwuru ma kwụsie ike maka otu ụbọchị ma ọ bụ karịa. O nwere okpukpu atọ karịa nke isi ihe dị na 1 ml nke ihe ngwọta. A na-ewepụta insulin nwayọ nwayọ ma banye n'ọbara, ka ị nwee ike ijikwa ogo nke glucose dị n'ọbara ụbọchị ụbọchị niile.
Kedu nke dị ọnụ ala?
Lantus bụ ọgwụ dị ọnụ ala. Ọnụ ego ya bụ 4000 rubles. Tujeo na-akwụ ihe dị ka 5500 rubles.
Kedu nke ka mma - Tujeo Solostar ma ọ bụ Lantus?
Ndị dọkịta na-edepụta Tujeo ugboro ugboro n'ihi A na-ahụta ka ọ dị irè karị. Site na ntinye nke otu insulin ahụ, olu ọgwụ a bụ 1/3 nke dose nke Lantus. Nke a na - enyere aka belata mpaghara mkpọda, na - eduga n'ịhapụ ọrụ nwayọ.
Ndị ọrịa na-ewere ya yikarịrị ka ha ga-ebute ọrịa hypoglycemia.
Enwere ike iji Tujeo Solostar mee ihe kama iji Lantus na nke ọzọ?
N'agbanyeghị eziokwu ahụ bụ na ọgwụ abụọ ahụ nwere otu ihe mejupụtara, ha enweghị ike dochie ibe ha kpamkpam. Emere nke a dika iwu siri ike. N'ime ọnwa mbụ iji ọgwụ ọzọ, ọ dị mkpa iji nlezianya nyochaa metabolic.
A na-eme mgbanwe site na Lantus ruo Tujeo na ọnụego otu n'otu. Ọ bụrụ na ọ dị mkpa, jiri nnukwu dose. N'ihe banyere ntụgharị mgbanwe, a na-ebelata insulin site na 20%, yana ndozi ya na-esote. Nke a dị mkpa iji belata ohere nke ịmalite hypoglycemia.
Nyocha nyocha Ndidi
Marina, 55 afọ, Murmansk: "Ana m agbanye Lantus kwa abalị. Site na ya, a na-echekwa shuga ọbara m na ọkwa a chọrọ n'abalị niile na ụbọchị niile. Ana m agbanye ọgwụ ahụ n'otu oge ahụ ka a na-enwe mmetụta ọgwụgwọ ahụ mgbe niile."
Dmitry, 46 afọ, Dimitrovgrad: "Dọkịta nyere Tujeo Solostar ọgwụ maka ọrịa m. Ọ dị mma iji ọgwụ a, n'ihi na ọ bụ onye na-ahọrọ mkpịsị sirinji na-achịkwa ya. Mgbe ọ jiri ya, shuga kwụsịrị ịwụ elu nke ukwuu na enweghị mmeghachi mmejọ ọ bụla."
Nyocha nke ndị dọkịta gbasara Tujeo Solostar na Lantus
Andrei, endocrinologist, Omsk: "M na-edenyekarị ndị ọrịa Lantus ọgwụ. Ọ bụ ọgwụ dị irè na-adịgide ihe dị ka otu ụbọchị. Ọ bụ ezie na ọ bụ ọgwụ dị oke ọnụ, ọ dị irè ma ọ nweghị mmetụta ọ bụla."
Antonina, endocrinologist, Saratov: "Ọgwụ Tujeo Solostar egosipụtara na ọ dị mma n'ọrịa shuga mellitus, yabụ m na-edenye ya ndị ọrịa oge niile. N'ihi nkesa otu nke ọgwụ ndị dị na ahụ, a na-ebelata ihe ize ndụ nke ịmalite hypoglycemia, karịsịa n'abalị. Ọ dị mkpa iji nlezianya lelee usoro iji gbochie hyperglycemia." .
